CNE000001CL7
CNE000001CL7
JIANGSU KANION PHARMACEUTICAL C
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.292.900.188 | 3.897.668.542 | 15.5% |
| Cost of Revenue | 940.309.997 | 1.043.897.392 | 9.9% |
| Gross Profit | 2.352.590.191 | 2.853.771.150 | 17.6% |
| 1.977.612.400 | 2.467.760.334 | 19.9% | |
| Operating Income | 374.977.791 | 386.010.815 | 2.9% |
| Pretax Income | 356.566.101 | 384.763.978 | 7.3% |
| Net Income Common Stockholders | 303.930.818 | 391.862.071 | 22.4% |
| -- | -- | -- | |
| -- | -- | -- |